chrisvoncsefalvay/vaers-outcomes huggingface dataset:
BACK HURT; HEADACHE; FATIGUED; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced back hurt, headache, and fatigued. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, back hurt and fatigued was not reported. This report was non-serious.
Red rash, hard to the touch and hot to touch for 7 hours. To take BENADRYL 25 mg every 6 hours and Ibuprofen 200 mg 2 every 6 hours.
This spontaneous report as received from a other health professional refers to a patient of unknown age. On 31-MAY-2017 the patient was vaccinated with improperly stored dose of VARIVAX lot # L040419 with an expiration date 14-OCT-2017 for prophylaxis. There was no adverse effect reported. Administered dose of VARIVAX experienced the temperature excursion from 15 degrees Fahrenheit to 46 degrees Fahrenheit for 10 minutes. There was previous temperature excursion from 15 degrees Fahrenheit to 46 degrees Fahrenheit for 10 minutes. A digital data logger was involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1707USA000408: US-009507513-1707USA000412: US-009507513-1706USA004091: US-009507513-1707USA000411: US-009507513-1707USA000407: US-009507513-1707USA000409.
Injection site red & swollen about 2 inches wide 6 inches long at ZOSTAVAX site -  still getting worse on 11/20/12 FLUZONE site red, swollen & sore to touch about the size of a dime.
BODY ACHES; FEELING HOT; BEING IN BED THE WHOLE DAY; BAD HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced body aches, feeling hot, being in bed the whole day, and bad headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the body aches, feeling hot, bad headache and being in bed the whole day was not reported. This report was non-serious. This case, from the same reporter is linked to 20210420044, 20210422653 and 20210420756.
Information has been received from a nurse referring to a 73 years old patient of unknown gender. The patient's medical history, concurrent condition and concomitant medication were unknown. On 29-AUG-2016, the patient was inadvertently vaccinated with a dose of GARDASIL 9 (dose, route, lot# and expiration date unknown) (Inappropriate schedule of drug administration). No adverse effects reported. Additional information has been requested.
This spontaneous report as received from a physician refers to an unspecified number of patients (unknown age and gender). In January 2014 (within the last week), the patients were vaccinated with an unspecified number of doses of improperly stored VARIVAX (merck) (lot number, dose and route of administration were not reported). No adverse event was reported. Additional information is not expected.
Arm started to itch at the injection site; Injection site red; Injection site swollen; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INJECTION SITE PRURITUS (Arm started to itch at the injection site), INJECTION SITE ERYTHEMA (Injection site red) and INJECTION SITE SWELLING (Injection site swollen) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced INJECTION SITE PRURITUS (Arm started to itch at the injection site), INJECTION SITE ERYTHEMA (Injection site red) and INJECTION SITE SWELLING (Injection site swollen). At the time of the report, INJECTION SITE PRURITUS (Arm started to itch at the injection site), INJECTION SITE ERYTHEMA (Injection site red) and INJECTION SITE SWELLING (Injection site swollen) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. The patient reported the redness is like a rash that started as a patch of red and moves every day. It has moved one inch to the elbow and towards underneath her arm. She went to her doctor, who instructed her to contact Moderna.
scratchy throat; flushed feeling; beginning of hives (raised welts); This is a spontaneous report from a contactable consumer (patient).  A 40-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in arm left on 28Jan2021 14:00 (Batch/Lot number was not reported) as single dose at the age of 40-year-old for COVID-19 immunisation .  Medical history included congenital heart defects, Eegs allergy. The patient's concomitant medications in two weeks were none. Patient was not pregnant. Prior to vaccination, the patient was diagnosed with COVID-19. The patient previously took phenergan, demerol and hydrocodone and experienced drug hypersensitivity. No other vaccine in four weeks.  Within 5-10 minutes the patient experienced scratchy throat, flushed feeling and beginning of hives on 28Jan2021 02:15. Patient received treatment with Benadryl for the events. COVID was not tested post vaccination. The outcome of events was recovered in 2021.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
The day after her immunizations, the patient reports to me a swollen upper arm and sensitive to touch.  She denies other symptoms at this time.
Lightheadedness; Patient reported Dizziness which subsided after being on close monitoring for 15 minutes.
The event started around 11:30 am with a ?blind spot? in peripheral vision in my right eye. For example, when I was typing on the keyboard the keys on the edge of my right-side field of view would be in a ?blind spot?. Then immediately after during lunch with my mom, I was having trouble recalling specific names and terms during conversation, and if she referred to someone specific like a neighbor who I know, I would need to pause and think about who she was talking about (e.g., which neighbor is that, again?). Otherwise, my speech, hearing, and balance were normal, and my mom did not notice anything out of the ordinary. But I definitely noticed it.  I was back to ?normal? after about an hour.
Patient presented at a mobile clinic, an assisted living facility where she lives. She Informed the vaccination team that she wanted to get a Covid booster shot and filled out a consent form. After the dose was administered, it was discovered that she had just received her 2nd dose in the series one week previously at another clinic. The 3rd booster dose was given too soon after the 2nd dose. As of today, no adverse events have been witnessed after this administration error.
rash; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced rash on an unspecified date. She asked if she could take antihistamine since she had rash after the first dose. The outcome of the event was unknown.  Follow-up attempts completed. No further information expected.
ADMINISTRATION ERROR; OFF LABEL USE; GOT MORE THAN HALF DOSE; PATIENT FELT LIQUID ON THEIR ARM; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A and expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 09-APR-2021, the subject experienced administration error. On 09-APR-2021, the subject experienced off label use. On 09-APR-2021, the subject experienced got more than half dose. On 09-APR-2021, the subject experienced subject felt liquid on their arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the administration error, off label use, got more than half dose and patient felt liquid on their arm was not reported. This report was non-serious.
Swelling under left armpit which began 48 hours after booster shot and has not gone away as of 72 hours post shot. Swelling is very fluid like
Information has been received from a physician, concerning a 60-year-old female patient with chronic cervical radiculopathy, lumber radiculopathy, depression, hyperlipidemia, hypertension, overweight, insomnia and allergies to LEVAQUIN and penicillin, who on 20-OCT-2008 received a dose of 0.5 ml PNEUMOVAX (lot # 661529/0868X, injection site unknown) via intramuscular route. Concomitant therapies included CRESTOR, HALCION, ibuprofen, levothyroxine Na, metoprolol, MAXZIDE, potassium (unspecified) and multi-vitamins (unspecified). On the same day as the administration, the patient developed pain and swelling at the injection site. On the next day, she had swelling of the arm. On 22-OCT-2008, the 3rd day, she experienced lots of erythema and pain. The patient went to the ER on 22-OCT-2008. She had chills and fever. Blood cultures were negative. CBC count was 17,000 with the left shift. She was treated with IV ROCEPHIN and IV vancomycin on an outpatient basis. Patient was on LORTAB for the pain and oral clindamycin and KEFLEX. At the time of reporting, the patient was recovering from the events. Follow-up information has been received from the physician concerning the 60-year-old female patient, who on 20-OCT-2008 received a first dose of PNEUMOVAX (lot number unknown, previously reported as 661529/0868X) via intramuscular route in her left deltoid at 5:00 PM. The patient had onset of severe painful erythematous swelling and fever 1 day after the PNEUMOVAX vaccine. Complete blood count (CBC) on an unspecified date was normal. She was treated with KEFLEX and NSAIDS but her symptoms worsened and she received 1 week of IV ROCEPHIN and IV vancomycin. On 07-NOV-2008, her symptoms resolved. This is one of two reports from the same source. No further information is available.
Systemic: Fainting / Unresponsive-Medium, Additional Details: pt received pfizer vaccine and around 5 minutes later pt fainted. pt was unconscious for a short period of time around 45 seconds. blood pressure, and pulse ox within normal range. we contacted emergency services, they came to monitor the pt he fainted again and they took him to the hospital.
Sudden, achy pain in most of my joints, widespread inflammation, particularly in hands and feet, calves. Almost every movement resulted in pain, sometimes severe. Severe anemia/iron deficiency.
Started to experience mild pain at the injection site that increased to extreme pain that radiated to fingertips and back up to jaw line. Started experiencing chest pains approx. 40 minutes post injection. Pain continued to radiate from jawline to fingertips for 5 1/2 hours post injection. Tylenol was administered 10 minutes post injection. Pain became so intense that patient reported unable to lift or move arm and began to experience nausea. Pt did not go to ER as pt is a nurse and did not feel there was any indiacated treatment options.
Diarrhea; Abdominal pain; Nausea; Vomiting; fatigue; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), ABDOMINAL PAIN (Abdominal pain), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced PYREXIA (Fever) and CHILLS (Chills). On 14-Mar-2021, the patient experienced DIARRHOEA (Diarrhea), ABDOMINAL PAIN (Abdominal pain), NAUSEA (Nausea), VOMITING (Vomiting) and FATIGUE (fatigue). On 13-Mar-2021, PYREXIA (Fever) and CHILLS (Chills) had resolved. At the time of the report, DIARRHOEA (Diarrhea), ABDOMINAL PAIN (Abdominal pain), NAUSEA (Nausea), VOMITING (Vomiting) and FATIGUE (fatigue) outcome was unknown.            Treatment using bismuth subsalicylate diarrhea and stomach pain was reported  Action taken with mRNA-1273 in response to the events was not applicable.
pt reported lightheadedness, dizziness, queasiness, periodic rushes in heartbeat, legs feeling wobbly soon p/vax;referred to MD of choice;MD recommended to go home & rest;MD felt pt was exp a rxn to the vax;exp T99 & one episode of vomiting
Client states that approximately 4 hours after receiving the Flucelvax, her eyelids began to swell.  Especially the left eyelid.
Extreme muscle pain in lower right area of back.  I had some pain the next morning after the shot (2/5) where I couldn't move, but it gradually got better (I took Tylenol 8 hour and 2 Aleves) by noon and I got out of bed. Sunday night (2/6), around 8:45pmET, I had a shooting pain in my lower right back and I could no longer move.  I was sitting on a bed with my youngest child at the time (with no sudden movements).  The pain was so difficult to manage that my husband brought a chair for me because I could not walk to my bed or down 2 little steps to my room to rest.  I sat in the chair for an hour before trying again to move and again, I had to use my husband for support.  He helped me lay into bed that evening and I could not even turn my body without pain.  I used ice compresses and heat that relieved the pain somewhat, but I have never experienced anything like this before.  I was laying down and did not get of bed until 1pm on Monday morning (2/7) -again with assistance.  I stood up leaning on a  5 drawer chest on my room and my husband brought some food and tea for me since I didn't eat and drink (for fear of having to go to the bathroom).  After another 30 minutes, I started using the back of a rolling chair for assistance to walk.  By 2pm, I had enough energy/stamina to slowly make it down the stairs.  I made sure not to sit again and just slowly keep moving.  We finally managed to see the dr. later that day/evening.
This spontaneous report has been received from a pharmacist concerning a 22 year old patient of unknown gender. The patient's medical history, drug allergies, concurrent conditions and concomitant therapies were not reported. On 15-SEP-2017 the patient was vaccinated with an expired dose of GARDASIL 9 with lot number L007560 and expiration date on 15-JUN-2017, for prophylaxis (dose, dose number and route of administration were not provided). No adverse effects were reported.
Mother reports child woke up this morning about 8:30 AM with red rash "hives" on legs, arms and face. Mother gave child 1 tsp Benadryl and is waiting for doctor's office to open at 10 AM. Mother called PP and was instructed to stay on Benadryl dosing. If child worsened then to see PP. 12/15/03 child's hives resolved in 24 hours. Did not see PP. But has well child appt in 1 week and will ask PP if second dose of flu is recommended.
Generalised skin rash throughout the body. prutitus, felt at around 4:00am. Went to ER at around 9:00am - Prednisone 10mg was prescribed PO/qid/ for 5 days, then 10mg PO/bid for 3 days, 10mg once for 2days. Second treatment Prednisone PO 20mg PO, once a day for five days. Atarax 50mg PO q6h PRN.
The patient experienced no symptoms.; an expired dose of VAQTA was administered to a patient on 12/2/2019.; This spontaneous report has been received from a nurse refers to a patient of unknown age and gender. Information about medical history, concurrent conditions, concomitant therapies and drug allergies was not provided.      On 02-DEC-2019, the patient was vaccinated with a dose of expired hepatitis a vaccine, inactivated (VAQTA) 25/0.5 (unknown unit)(lot #: R034339, expiration date: 23-NOV-2019; strength, frequency and dose details were unknown) intramuscularly for prophylaxis (expired product administered). The patient experienced no symptoms.
Information has been received from a nurse practitioner concerning a 14 year old female who on 06-AUG-2007 was vaccinated with a dose of Gardasil.  Concomitant therapy included MENACTRA and VARIVAX.  The patient experienced syncope after vaccination.  Within the 15 minutes of observation after vaccination the patient got dizzy.  Medical attention was sought.  Symptoms had resolved.  Additional information has been requested.
Initial and follow-up information has been received from a physician concerning a 16 year old female with no medical history, who on 10-OCT-2007 was vaccinated with a first dose of GARDASIL (Lot# 658282/1263U). Concomitant vaccinations included MENACTRA. Concomitant therapies started on 16-OCT-2007 included ceftriaxone sodium 125mg used to treat Gonorrhoea and azithromycin 1gm used to treat a Chlamydial infection. Subsequently, the patient was pregnant. The patient's last menstrual period was 26-SEP-2007 and her estimated delivery date was 02-JUL-2008. It was reported to be unknown if the patient had an ultrasound performed. The patient had no previous pregnancies and no full term deliveries. At the time of the report, the outcome of the patient was unknown. Follow-up information was received from the physician who reported that on 13-APR-2008 the patient had a emergency c-section for failure to progress and repetitive severed deceleration. The patient delivered a male baby, birth weight 6 lb 12 oz. length 481/2 inch, Apgar score 9/9. It was reported that the baby did not have any congenital abnormalities or other complications or abnormalities. Upon internal review, failure to progress and repetitive severed deceleration which resulted in an emergency cesarean section were considered to be other important medical events. Additional information is not expected.
She cannot move hand all the way up; Injection site feels warm to the touch; Injection site is swollen; Injection site is painful; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Soreness), INJECTION SITE WARMTH (Injection site feels warm to the touch), PERIPHERAL SWELLING (Injection site is swollen), INJECTION SITE PAIN (Injection site is painful) and MOVEMENT DISORDER (She cannot move hand all the way up) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced ARTHRALGIA (Soreness), INJECTION SITE WARMTH (Injection site feels warm to the touch), PERIPHERAL SWELLING (Injection site is swollen), INJECTION SITE PAIN (Injection site is painful) and MOVEMENT DISORDER (She cannot move hand all the way up). At the time of the report, ARTHRALGIA (Soreness), INJECTION SITE WARMTH (Injection site feels warm to the touch), PERIPHERAL SWELLING (Injection site is swollen), INJECTION SITE PAIN (Injection site is painful) and MOVEMENT DISORDER (She cannot move hand all the way up) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Soreness at injection site, dry cough, hoarseness, headache, itching. Fast heart beat past midnight.
Throat and tongue swelled, mouth and throat extremely red, blisters all over inside of mouth.  Tired more than usual. Loss of appetite and headache that came and went. It?s been about three weeks and my throat is just a little sore, my taste is more intense, and I?ve noticed I still tire by afternoon
No adverse effects were reported; the patient was inadvertently administered a dose of expired MMR II; This spontaneous report has been received from a pharmacist referring to a patient of unknown age. The patient's concomitant therapy included sterile diluent. Pertinent medical history and drug reactions/allergies were not reported.  On 17-APR-2019, the patient was inadvertently vaccinated with a dose of expired measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (lot # N009171, expiration date 20-MAR-2019; dose was unknown) subcutaneously for prophylaxis (expired vaccine used). No temperature excursion. No adverse effects were reported. The outcome of the events was unknown. No product quality complaint (PQC) presented.
This in follow-up to report (s) previously submitted on 10/12/2007. Information has been received from a Registered Nurse (R.N.) concerning a female patient who was vaccinated IM with a second dose of GARDASIL.  The nurse mentioned that after the second injection the patient experienced "injection site itchiness and redness that lasted 15 days".  Unspecified medical attention was sought by the patient.  No further information was provided.  The outcome was unknown.  Additional information has been requested. Additional information is not expected.
Holding breath while immunizations given. Eyes rolled back in head, went limp and turned blue. After a few seconds, eyes opened took breath, color improved. Then went limp and turned blue again lasting several seconds. Gave O2 and observed.
Patient reports no adverse symptoms or signs.  Given phone number to Gardasil 9 Registry.
First  one fatigue and soreness on injection site. Second on Migraine, chills fatigue the day of the vaccine. next day sleep a lot, Dealing with fever, chills, body aches real bad. Tightness in her chest. Took anxiety medication, diarrhea and vomiting, knees hurt so bad she could not walk. Arm real sore migraine so bad she barely open her eyes sensitive to light. Called the advise nurse and she advised her get a COVID test and she has an appointment with physician today.